Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;17(2):235-248.
doi: 10.1038/s44321-024-00190-3. Epub 2025 Jan 10.

Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer's disease

Affiliations

Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer's disease

Davina Biel et al. EMBO Mol Med. 2025 Feb.

Abstract

In Alzheimer's disease (AD), Aβ triggers p-tau secretion, which drives tau aggregation. Therefore, it is critical to characterize modulators of Aβ-related p-tau increases which may alter AD trajectories. Here, we assessed whether factors known to alter tau levels in AD modulate the association between fibrillar Aβ and secreted p-tau181 determined in the cerebrospinal fluid (CSF). To assess potentially modulating effects of female sex, younger age, and ApoE4, we included 322 ADNI participants with cross-sectional/longitudinal p-tau181. To determine effects of microglial activation on p-tau181, we included 454 subjects with cross-sectional CSF sTREM2. Running ANCOVAs for nominal and linear regressions for metric variables, we found that women had higher Aβ-related p-tau181 levels. Higher sTREM2 was associated with elevated p-tau181, with stronger associations in women. Similarly, ApoE4 was related to higher p-tau181 levels and faster p-tau181 increases, with stronger effects in female ApoE4 carriers. Our results show that sex alone modulates the Aβ to p-tau axis, where women show higher Aβ-dependent p-tau secretion, potentially driven by elevated sTREM2-related microglial activation and stronger effects of ApoE4 carriership in women.

Keywords: Alzheimer’s Disease; Microglia; Sex Differences; p-tau; sTREM2.

PubMed Disclaimer

Conflict of interest statement

Disclosure and competing interests statement. The authors declare no competing interests.

Figures

Figure 1
Figure 1. Main effects of potential modulators and CSF p-tau181 across Aβ− cognitively normal plus Aβ+ ranging from cognitively normal to AD demented (longitudinal sample: N = 322; sTREM2 sample: N = 454).
Significant main effects were found between CSF sTREM2 and cross-sectional CSF p-tau181 (C, p < 2e−16) and between ApoE4 carriership (non-carriers: n = 185; carriers: n = 137) and cross-sectional (F, p = 7.69e−11) and longitudinal (G) p-tau181 levels. Sex (male: n = 156; female: n = 166) (A, B) and age (D, E) were not associated with higher p-tau181 levels or faster p-tau181 increases. F and p-values were derived for nominal variables (A, B, F, G) from ANCOVAs, and standardized beta-estimates (β) and p-values were derived for metric variables (C, D, E) from linear regressions. (A) and (B) were controlled for age, education, clinical status, and amyloid-PET (in centiloid); (C), (F), and (G) were controlled for sex, age, education, clinical status, and centiloid; (D) and (E) were controlled for sex, education, clinical status, and centiloid. The center line of each boxplot (A, B, F, G) indicates the median (50th percentile), the bounds of the box show the interquartile range (25–75th percentiles), and the whiskers extend to 1.5 times the interquartile range from the edges of the box. * = pFDR < 0.05.
Figure 2
Figure 2. Interaction effects of potential modulators on the association between amyloid-PET (in centiloid) and CSF p-tau181 across Aβ− cognitively normal plus Aβ+ ranging from cognitively normal to AD demented (longitudinal sample: N = 322; sTREM2 sample: N = 454).
A significant interaction effect was found between centiloid and sex (male: n = 156; female: n = 166) on cross-sectional (A) and longitudinal (B) p-tau181 levels (B only borderline significant after FDR correction). No significant interaction effects were found between centiloid and sTREM2 (C), age (D, E) or ApoE4 status (non-carriers: n = 185; carriers: n = 137) (F, G) on cross-sectional/longitudinal p-tau181 levels. Standardized beta-estimates (β) and p-values were derived from linear regressions. (A) and (B) were controlled for age, education, and clinical status; (C), (F), and (G) were controlled for sex, age, education, and clinical status, and (D) and (E) were controlled for sex, education, and clinical status. * = pFDR < 0.05; # = pFDR < 0.1.
Figure 3
Figure 3. Sex as modulator for the effects of CSF sTREM2 and ApoE4 carriership on CSF p-tau181 across Aβ− cognitively normal plus Aβ+ ranging from cognitively normal to AD demented (ApoE4 sample: N = 322; sTREM2 sample: N = 454).
Female sex compared to male sex (male: n = 244; female: n = 210) is associated with a stronger association between sTREM2 and p-tau181 levels (A). Stronger association between ApoE4 carriership (non-carriers: n = 185; carriers: n = 137) and p-tau181 in women than in men (B). 3-way interaction effect of centiloid, sTREM2, and sex on p-tau181 levels with women showing a stronger association between centiloid and p-tau181 with increasing sTREM2 levels (β = 0.312, T = 2.316, p = 0.021, pFDR = 0.063) (C). Standardized beta-estimates (β) and p-values were derived from linear regressions. (A) and (B) were controlled for age, education, clinical status, and centiloid. (C) was controlled for age, education, and clinical status. The center line of the boxplot (B) indicates the median (50th percentile), the bounds of the box show the interquartile range (25–75th percentiles), and the whiskers extend to 1.5 times the interquartile range from the edges of the box. * = pFDR < 0.05.

References

    1. Altmann A, Tian L, Henderson VW, Greicius MD, Alzheimer’s Disease Neuroimaging Initiative I (2014) Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol 75:563–573 - PMC - PubMed
    1. Alzheimer’s A (2014) 2014 Alzheimer’s disease facts and figures. Alzheimers Dement 10:e47–92 - PubMed
    1. Asaro A, Carlo-Spiewok AS, Malik AR, Rothe M, Schipke CG, Peters O, Heeren J, Willnow TE (2020) Apolipoprotein E4 disrupts the neuroprotective action of sortilin in neuronal lipid metabolism and endocannabinoid signaling. Alzheimers Dement 16:1248–1258 - PubMed
    1. Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC (2011) A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 54:2033–2044 - PMC - PubMed
    1. Babapour Mofrad R, Tijms BM, Scheltens P, Barkhof F, van der Flier WM, Sikkes SAM, Teunissen CE (2020) Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE epsilon4 genotype. Neurology 95:e2378–e2388 - PubMed

LinkOut - more resources